Crosstalk between Complement and Toll-Like Receptors

被引:75
|
作者
Song, Wen-Chao [1 ,2 ]
机构
[1] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
complement; TLR; innate immunity; inflammation; cytokines; ADAPTIVE IMMUNE-RESPONSES; HEMOLYTIC-UREMIC SYNDROME; INNATE IMMUNITY; ALTERNATIVE PATHWAY; CELL-ACTIVATION; T-CELLS; SIGNAL-TRANSDUCTION; AUTOIMMUNE-DISEASE; DENDRITIC CELLS; DROSOPHILA TOLL;
D O I
10.1177/0192623311428478
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The complement system and toll-like receptors (TLRs) are two components of innate immunity that are critical for first-line host defense. Many pathogen-associated molecular patterns activate both complement and TLRs, and recent studies in animal models have revealed a marked synergistic interaction between the two systems. In mice deficient in a membrane complement regulator, prototypical TLR ligands such as LPS, zymosan, and polyI:C caused increased systemic complement activation, which in turn led to a profound elevation of proinflammatory cytokine biosynthesis. This phenotype required interaction between complement and TLRs because complement activation alone by cobra venom factor without TLR engagement did not lead to appreciable cytokine production. The regulatory effect of complement on TLR signaling was mediated by the anaphylatoxins C5a and C3a through a receptor-dependent mechanism and involved increased mitogen-activated protein kinase and nuclear factor kappa B activation. The crosstalk between complement and TLRs may also impact adaptive immunity, for example, the differentiation of T helper 17 (Th-17) cells. Given that excessive activation of either TLR or complement has been associated with inflammatory tissue injury as occurs in sepsis and autoimmune diseases, the new insight on complement and TLR crosstalk may have therapeutic implications.
引用
收藏
页码:174 / 182
页数:9
相关论文
共 50 条
  • [31] Complement and Toll-like receptors:: Key regulators of adaptive immune responses
    Hawlisch, H
    Köhl, J
    MOLECULAR IMMUNOLOGY, 2006, 43 (1-2) : 13 - 21
  • [32] Toll-like receptors as adjuvant receptors
    Kaisho, T
    Akira, S
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2002, 1589 (01): : 1 - 13
  • [33] Interdependencies between Toll-like receptors in Leishmania infection
    Shukla, Divanshu
    Patidar, Ashok
    Sarma, Uddipan
    Chauhan, Prashant
    Pandey, Surya Prakash
    Chandel, Himanshu Singh
    Bodhale, Neelam
    Ghosh, Soumya Kanti
    Guzman, Carlos Alberto
    Ebensen, Thomas
    Silvestre, Ricardo
    Sarkar, Arup
    Saha, Bhaskar
    Bhattacharjee, Surajit
    IMMUNOLOGY, 2021, 164 (01) : 173 - 189
  • [34] Toll-like receptors in neurodegeneration
    Okun, Eitan
    Griffioen, Kathleen J.
    Lathia, Justin D.
    Tang, Sung-Chun
    Mattson, Mark P.
    Arumugam, Thiruma V.
    BRAIN RESEARCH REVIEWS, 2009, 59 (02) : 278 - 292
  • [35] Viruses and toll-like receptors
    Rassa, JC
    Ross, SR
    MICROBES AND INFECTION, 2003, 5 (11) : 961 - 968
  • [36] Avian toll-like receptors
    Robert Brownlie
    Brenda Allan
    Cell and Tissue Research, 2011, 343 : 121 - 130
  • [37] Toll-like receptors and ageing
    Yang, XF
    Li, GZ
    Alaverdi, N
    Endaya, A
    Pangulayan, G
    Reyes, A
    Lai, L
    FASEB JOURNAL, 2002, 16 (04): : A292 - A292
  • [38] Toll-like receptors and diseases
    Iribarren, Pablo
    Wang, Ji Ming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (10) : 1389 - 1390
  • [39] Toll-Like Receptors in Angiogenesis
    Grote, Karsten
    Schuett, Harald
    Schieffer, Bernhard
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 981 - 991
  • [40] Toll-like receptors in the spotlight
    Luke A.J. O'Neill
    Zarin Brown
    Stephen G. Ward
    Nature Immunology, 2003, 4 : 299 - 299